We at Shareholders Unite are retired university professors from Amsterdam writing with a focus on small-cap, macro, value, and momentum.
Our analysis can be read on both TalkMarkets and more
We at Shareholders Unite are retired university professors from Amsterdam writing with a focus on small-cap, macro, value, and momentum.
Our analysis can be read on both TalkMarkets and Seeking Alpha.
less
Latest Comments
Orgenesis' Leveraged Approach To Lower The Cost Of Cell And Gene Therapies
Well, anything in the cell & gene therapy space, in theory, but it really depends on the therapy in question, and even that might not be a problem because Orgenesis argues they are doing things cheaper.
Orgenesis' Leveraged Approach To Lower The Cost Of Cell And Gene Therapies
My pleasure Alexa. It's a pretty complex company, perhaps it's more like a little network, as it happens.
Medigus Is Facing Multiple Opportunities But Is Not Without Risk
Yes, it's like a mini-conglomerate
Medigus Is Facing Multiple Opportunities But Is Not Without Risk
Yep, that's possible Adam, it's interesting tech which does good in medical appliances, but as with much tech, in the wrong hands it can do damage..
Medigus, A High-Risk, High-Reward Micro-Camera Play
Yep, they have some interesting technology which is applicable in numerous situations.
Nxt-ID Gets A New Lease On Life
Will let you know what they answered ASAP.
Nxt-ID Gets A New Lease On Life
I'm not sure what the hold-up is, as puzzled as the commentators but I've contacted the company, stay tuned..
Nxt-ID Gets A New Lease On Life
It's difficult to value FitPay at the moment but LogicMark without having to finance the finance business looks pretty good to us on a valuation basis.
Nxt-ID Gets A New Lease On Life
There's not really much we can do about that Dan..
Nxt-ID Gets A New Lease On Life
Thanks Dick, my pleasure